Derivados guanilhidrazônicos como antibacterianos e moduladores da resistência a drogas em Staphylococcus aureus

• Ano de defesa: 2015
• Autor(a) principal: Dantas, Natalina
• Tipo de documento: Dissertação
• Tipo de acesso: Acesso aberto
• Idioma: por
• Instituição de defesa: Universidade Federal da Paraíba; Brasil; Biologia Celular e Molecular; Programa de Pós-Graduação em Biologia Celular e Molecular; UFPB
• Palavras-chave em Português: Staphylococcus aureus; Resistência bacteriana; Inibidor de bomba de efluxo; Guanilhidrazonas; Guanidina; Resistance bacterial; Efflux pump inhibitor; Guanylhydrazones; Guanidine; CIENCIAS BIOLOGICAS::BIOLOGIA GERAL
• Link de acesso: https://repositorio.ufpb.br/jspui/handle/tede/9470

The mutual ineffective for many antibiotics called multidrug resistance (MDR), has undermined the therapeutic value of existing antibacterial. With the identification and characterization of efflux systems that confer clinical resistance to antimicrobial, has emerged interest in developing a new class of agents enhancers the antibiotic action that act as inhibitors of efflux pumps, this are also called antibiotic activity modifiers or antibiotics adjuvantes. In this study, were evaluated synthetic guanylhydrazones derivatives as antibacterial and agents modulators of drug resistance in strains of Staphylococcus aureus. The bacterial strains used express the genes NorA, MrsA or TetK encoding proteins efflux for norfloxacin and ethidium bromide (NorA), erythromycin (MsrA) and tetracycline(TetK), respectively. The minimum inhibitory concentrations (MIC) values of the antibiotics and synthetic derivatives were determined in nutrient broth by the microdilution assay, and to evaluate the modulator activity, the MIC of antibiotics and ethidium bromide were determined in the absence and presence of subinibitory concentrations of guanylhydrazones. The compounds tested did not display relevant antibacterial activity for majority compounds at the concentrations tested, showing MIC ranging from (16 to > 256 μg/mL). When combined with the antibiotics tetracycline and erythromycin some compounds reduced their MIC 2-fold and 4-fold respectively. However, when combined with norfloxacin, except only one compound, all guanylhydrazones derivatives in different ratios and degrees of sensitivity, were able to potentiate the effect of this antibiotic, with three compounds which reduced its MIC 16-fold to norfloxacin, 32-fold to ethidium bromide and 8-fold for berberine used as positive controls for NorA pump. The molecular docking studies showed that both norfloxacin and compound 13 are recognized by the same binding site on the NorA pump, suggesting a competitive mechanism. The results presented here reported for the first time its great potential of guanylhydrazones derivatives to be putative inhibitors of bacterial efflux systems, especially for strains Staphylococcus aureus.